APLAR rheumatoid arthritis treatment recommendations

被引:128
作者
Lau, Chak Sing [1 ]
Chia, Faith [2 ]
Harrison, Andrew [3 ]
Hsieh, Tsu-Yi [4 ,5 ]
Jain, Rahul [6 ]
Jung, Seung Min [7 ]
Kishimoto, Mitsumasa [8 ]
Kumar, Ashok [9 ]
Leong, Khai Pang [2 ]
Li, Zhanguo [10 ]
Javier Lichauco, Juan [11 ]
Louthrenoo, Worawit [12 ]
Luo, Shue-Fen [13 ,14 ]
Nash, Peter [15 ]
Ng, Chin Teck [16 ]
Park, Sung-Hwan [7 ]
Suryana, Bagus Putu Putra [17 ]
Suwannalai, Parawee [18 ]
Wijaya, Linda Kurniaty [19 ]
Yamamoto, Kazuhiko [20 ]
Yang, Yue [10 ]
Yeap, Swan Sim [21 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Div Clin Immunol & Rheumatol, Hong Kong, Hong Kong, Peoples R China
[2] Tan Tock Seng Hosp, Dept Rheumatol Allergy & Immunol, Singapore, Singapore
[3] Univ Otago Wellington, Dept Med, Wellington, New Zealand
[4] Taichung Vet Gen Hosp, Sect Allergy Immunol & Rheumatol, Taichung, Taiwan
[5] Taichung Vet Gen Hosp, Sect Clin Skills Training, Taichung, Taiwan
[6] Narayana Hosp, Jaipur, Rajasthan, India
[7] Catholic Univ Korea, St Marys Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea
[8] St Lukes Int Hosp, Immunorheumatol Ctr, Tokyo, Japan
[9] Fortis Flt Lt Rajan Dhall Hosp, Dept Rheumatol, New Delhi, India
[10] Peking Univ, Peoples Hosp, Dept Rheumatol, Beijing 100871, Peoples R China
[11] St Lukes Med Ctr, Quezon City, Philippines
[12] Chiang Mai Univ, Fac Med, Dept Internal Med, Div Rheumatol, Chiang Mai 50000, Thailand
[13] Chang Gung Mem Hosp, Dept Rheumatol Allergy & Immunol, Taoyuan, Taiwan
[14] Chang Gung Univ, Taoyuan, Taiwan
[15] Univ Queensland, Dept Med, Brisbane, Qld 4000, Australia
[16] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore
[17] Brawijaya Univ, Saiful Anwar Gen Hosp, Dept Internal Med, Div Rheumatol, Malang, Indonesia
[18] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Internal Med,Allergy Immunol & Rheumatol Div, Bangkok 10400, Thailand
[19] Univ Indonesia, Dept Internal Med, Div Rheumatol, Jakarta, Indonesia
[20] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan
[21] Subang Jaya Med Ctr, Selangor, Malaysia
关键词
drug treatment; rheumatoid arthritis; MODIFYING ANTIRHEUMATIC DRUGS; TUMOR-NECROSIS-FACTOR; BRITISH HEALTH-PROFESSIONALS; ALPHA ANTAGONIST THERAPY; SOCIETY-FOR-RHEUMATOLOGY; EULAR RECOMMENDATIONS; CONSENSUS STATEMENT; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; CONCOMITANT METHOTREXATE;
D O I
10.1111/1756-185X.12754
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsRheumatoid arthritis is a chronic inflammatory condition that affects approximately 1% of the world's population. There are a wide number of guidelines and recommendations available to support the treatment of rheumatoid arthritis; however, the evidence used for these guidelines is predominantly based on studies in Caucasian subjects and may not be relevant for rheumatoid arthritis patients in the Asia-Pacific region. Therefore, the Asia Pacific League of Associations for Rheumatology established a Steering Committee in 2013 to address this issue. Materials and methodsThe AGREE II instrument and the ADAPTE Collaboration framework were applied to systematically identify, appraise, synthesize, and adapt international rheumatoid arthritis guidelines for use in the Asia-Pacific region. ResultsForty rheumatoid arthritis treatment recommendations, based on evidence and expert opinion, were drafted and are presented in this report. ConclusionThe Asia Pacific of Associations for Rheumatology rheumatoid arthritis treatment recommendations are intended to serve as a reference for best practice management of rheumatoid arthritis in Asia-Pacific, focusing on local issues to ensure the delivery of basic care for these patients, and to improve their outcomes. In addition, the document will serve as a reference for national rheumatology associations in Asia-Pacific for developing guidelines in their respective countries.
引用
收藏
页码:685 / 713
页数:29
相关论文
共 104 条
[1]   German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs [J].
Albrecht, Katinka t ;
Krueger, Klaus ;
Wollenhaupt, Juergen ;
Alten, Rieke ;
Backhaus, Marina ;
Baerwald, Christoph ;
Bolten, Wolfgang ;
Braun, Juergen ;
Burkhardt, Harald ;
Burmester, Gerd R. ;
Gaubitz, Markus ;
Gause, Angela ;
Gromnica-Ihle, Erika ;
Kellner, Herbert ;
Kuipers, Jens ;
Krause, Andreas ;
Lorenz, Hans-Martin ;
Manger, Bernhard ;
Nuesslein, Hubert ;
Pott, Hans-Georg ;
Rubbert-Roth, Andrea ;
Schneider, Matthias ;
Specker, Christof ;
Schulze-Koops, Hendrik ;
Tony, Hans-Peter ;
Wassenberg, Siegfried ;
Mueller-Ladner, Ulf .
RHEUMATOLOGY INTERNATIONAL, 2014, 34 (01) :1-9
[2]  
[Anonymous], 2018, RHEUMATOID ARTHRITIS
[3]  
[Anonymous], APLAR J RHEUMATOL
[4]   Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists [J].
Askling, Johan ;
Fored, C. Michael ;
Brandt, Lena ;
Baecklund, Eva ;
Bertilsson, Lennart ;
Feltelius, Nils ;
Coster, Lars ;
Geborek, Pierre ;
Jacobsson, Lennart T. ;
Lindblad, Staffan ;
Lysholm, Jorgen ;
Rantapaa-Dahlqvist, Solbritt ;
Saxne, Tore ;
van Vollenhoven, Ronald F. ;
Klareskog, Lars .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (10) :1339-1344
[5]   Canadian Rheumatology Association Recommendations for the Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs: Part II Safety [J].
Bombardier, Claire ;
Hazlewood, Glen S. ;
Akhavan, Pooneh ;
Schieir, Orit ;
Dooley, Anne ;
Haraoui, Boulos ;
Khraishi, Majed ;
Leclercq, Sharon A. ;
Legare, Jean ;
Mosher, Dianne P. ;
Pencharz, James ;
Pope, Janet E. ;
Thomson, John ;
Thorne, Carter ;
Zummer, Michel ;
Gardam, Michael A. ;
Askling, Johan ;
Bykerk, Vivian .
JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) :1583-1602
[6]   Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials [J].
Bongartz, T ;
Sutton, AJ ;
Sweeting, MJ ;
Buchan, I ;
Matteson, EL ;
Montori, V .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (19) :2275-2285
[7]   Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials [J].
Bongartz, T. ;
Warren, F. C. ;
Mines, D. ;
Matteson, E. L. ;
Abrams, K. R. ;
Sutton, A. J. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (07) :1177-1183
[8]   The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment [J].
Breedveld, FC ;
Weisman, MH ;
Kavanaugh, AF ;
Cohen, SB ;
Pavelka, K ;
van Vollenhoven, R ;
Sharp, J ;
Perez, JL ;
Spencer-Green, GT .
ARTHRITIS AND RHEUMATISM, 2006, 54 (01) :26-37
[9]   AGREE II: advancing guideline development, reporting and evaluation in health care [J].
Brouwers, Melissa C. ;
Kho, Michelle E. ;
Browman, George P. ;
Burgers, Jako S. ;
Cluzeau, Francoise ;
Feder, Gene ;
Fervers, Beatrice ;
Graham, Ian D. ;
Grimshaw, Jeremy ;
Hanna, Steven E. ;
Littlejohns, Peter ;
Makarski, Julie ;
Zitzelsberger, Louise .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (18) :E839-E842
[10]   Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis [J].
Buch, Maya H. ;
Smolen, Josef S. ;
Betteridge, Neil ;
Breedveld, Ferdinand C. ;
Burmester, Gerd ;
Doerner, Thomas ;
Ferraccioli, Gianfranco ;
Gottenberg, Jacques-Eric ;
Isaacs, John ;
Kvien, Tore K. ;
Mariette, Xavier ;
Martin-Mola, Emilio ;
Pavelka, Karel ;
Tak, Paul P. ;
van der Heijde, Desiree ;
van Vollenhoven, Ronald F. ;
Emery, Paul .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) :909-920